Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2025

Nov 24, 2025

31971_dirs_2025-11-24_dd80134c-3181-496e-8129-88be72cf3097.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2025-11-21

Reporting Person: Glaze Richard (Chief Information Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-21 Common Stock S 257 $41.21 Disposed 0 Direct